Cargando…
CD8(+) T cells: An ineffective armor against prolonged COVID-19 in cancer patients
In a diverse cohort of cancer patients, Lyudovyk et al.(1) show that persistent COVID-19 infection is associated with weaker humoral responses and increased CD8(+) T cell responses that are ineffective in clearing virus, particularly in patients receiving B cell-depleting therapies.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233996/ https://www.ncbi.nlm.nih.gov/pubmed/35835105 http://dx.doi.org/10.1016/j.xcrm.2022.100695 |